Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762.TW)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Qing-Peng Wei | General Manager | -- | -- | -- |
| Mr. Kuan-Chieh Wang | Manager of Finance Department & Head of Corporate Governance | -- | -- | -- |
| Guanjie Wang | Accounting Supervisor | -- | -- | -- |
| Mr. Jun-Jie Liao | Manager of Human Resource Office | -- | -- | -- |
| Mr. Chao-Sheng Hong | Chief Auditor | -- | -- | -- |
Chunghwa Chemical Synthesis & Biotech Co., Ltd.
- Sector:
- Healthcare
- Industry: Biotechnology
Description
Chunghwa Chemical Synthesis & Biotech Co., Ltd. engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (APIs) in Taiwan and the United States. It offers API products, which include immunosuppressant, oncology, anti-virus, immunomodulating agents, and other products, as well as peptide drugs. The company also develops bulk pharmaceutical products, such as anti-anxiety agents, antidiabetics, laxatives, antifungals, antihistamines, antiseptics, antiulcerants, cardiovascular drugs, skeletal, muscle relaxants, hypolipaemics, antineoplastic, antihyperlipedemias, and immunosuppressant products, as well as provides research and development, and contract manufacturing services. The company was formerly known as China Chemical Synthesis Industry Co., Ltd. Chunghwa Chemical Synthesis & Biotech Co., Ltd. was founded in 1964 and is based in New Taipei City, Taiwan.
Corporate Governance
Upcoming Events
August 4, 2025 at 10:59 AM UTC - August 8, 2025 at 12:00 PM UTC
Chunghwa Chemical Synthesis & Biotech Co., Ltd. Earnings Date
Recent Events
July 26, 2024 at 12:00 AM UTC
Ex-Dividend Date